Impact of pathogen reduction technology on neutralizing antibody titer in COVID-19 convalescent plasma
- PMID: 34391625
- PMCID: PMC8320387
- DOI: 10.1016/j.tracli.2021.07.006
Impact of pathogen reduction technology on neutralizing antibody titer in COVID-19 convalescent plasma
Figures

Comment on
-
Impact of pathogen-reduction technologies on COVID-19 convalescent plasma potency.Transfus Clin Biol. 2021 May;28(2):132-134. doi: 10.1016/j.tracli.2021.02.005. Epub 2021 Mar 3. Transfus Clin Biol. 2021. PMID: 33675992 Free PMC article.
References
-
- Yonemura S., Hartson L., Dutt T.S., Henao-Tamayo M., Goodrich R., Marschner S. Preservation of neutralizing antibody function in COVID-19 convalescent plasma treated using a riboflavin and ultraviolet light-based pathogen reduction technology. Vox Sang. 2021;9 doi: 10.1111/vox.13108. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical